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Abstract
Background: The MYC transcription factors are known to be involved in the biology of many human cancer types. But little
is known about the Myc/microRNAs cooperation in the regulation of genes at the transcriptional and post-transcriptional
level.
Methodology/Principal Findings: Employing independent databases with experimentally validated data, we identified
several mixed microRNA/Transcription Factor Feed-Forward Loops regulated by Myc and characterized completely by
experimentally supported regulatory interactions, in human. We then studied the statistical and functional properties of
these circuits and discussed in more detail a few interesting examples involving E2F1, PTEN, RB1 and VEGF.
Conclusions/Significance: We have assembled and characterized a catalogue of human mixed Transcription Factor/
microRNA Feed-Forward Loops, having Myc as master regulator and completely defined by experimentally verified
regulatory interactions.
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Introduction
MYC is one of the most intriguing oncogenes and presents the
challenging question of how a single gene can manifest so many
different effects. There are three Myc gene family members (c-
Myc, N-Myc and L-Myc), each with documented oncogenic
potential and similar DNA binding properties [1]. They encode
basic helix-loop-helix leucine zipper (bHLHZ) transcription
factors that are usually found as heterodimers with their obligate
partner, the small bHLHZ protein, Max [2]. For simplicity, we
will use in the following the term Myc to refer to all the three
proteins. Myc Transcription Factors (TFs) may act both as
activators or repressors of their Target genes and are involved in
a lot of key biological processes, ranging from cell cycle
progression to apoptosis and cellular transformation. Our
knowledge of Myc transcriptional targets has been greatly
enhanced in these last years by a set of high-throughput
screenings, which significantly expanded the list of genes that
are up or down regulated by Myc [3–6]. At the same time it has
also been realized that Myc TFs are involved in the regulation of
a broad range of microRNAs (miRNAs), many of which have key
roles in cell proliferation and oncogenic transformation [7–8]. In
this respect the Myc family is one of the most interesting
examples of TFs exerting at the same time a transcriptional and a
(miRNA mediated) post-transcriptional regulation on its targets.
It is natural to ask how these two levels of regulation are
coordinated and inter-related.
This question is part of a more general effort to understand the
interplay between transcriptional and post-transcriptional (miRNA
mediated) regulatory interactions which attracted much interest in
these last few years [9–16].
Among the various possible ways to integrate together TF-
mediated and miRNA-mediated interactions, a prominent role is
played by mixed Feed-Forward Loops (FFLs), in which a master
TF regulates a miRNA and together with it a set of protein coding
genes that are targeted by the same miRNA. These FFLs,
depending on the sign of the regulatory interactions, can be
divided in so called incoherent (type_I) or coherent (type_II)
circuits [10,12,15] (Figure 1). The two types of circuits may lead to
very different behaviours. In a typical coherent FFL the miRNA
expression is induced by an upstream TF that at the same time
represses the transcription of the Joint Target. In this case the
miRNA can help the transcriptional repression of a target protein
that should not be expressed in a particular cell type, acting as a
post-transcriptional failsafe control. Instead, an incoherent FFL
can promote high target expression in miRNA-expressing cells,
suggesting that miRNAs may have in this case a fine-tuning
function, keeping the protein level in the correct functional range
and, at the same time controlling the amount of cell to cell
fluctuations of the target proteins [10,17–18].
In a recent paper [12] we proposed a bioinformatic pipeline,
mainly based on an ab-initio sequence analysis for a genome wide
study of this class of mixed FFLs. We could obtain in this way a
total of 5030 different single target circuits (corresponding to 638
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randomization techniques we could show that these mixed FFLs
are remarkably over-represented in the regulatory network. The
major drawback of that analysis was that it was based only on
bioinformatic evidences and thus was in principle biased by our
assumptions on TF and miRNA binding sequences. The main
goal of this paper is to overcome this limitation by constructing a
set of mixed FFL in which all the regulatory links were supported
by experimental evidences and then use this set to perform
unbiased statistical and functional enrichment analysis.
To this end we concentrated our attention on the Myc TF and
built a curated database of human mixed miRNA/TF FFLs
having Myc as master regulator (Figure 1a) and characterized only
by experimental supported regulatory connections (Figure 1b).
This choice had two main motivations. The first is that, as we
discussed above, Myc is a TF of crucial importance in several
biological processes. The second is that for this particular TF a lot
of experimental data exist thus allowing us to construct a database
large enough to perform reliable statistical and functional analysis.
Results and Discussion
In this section we report a list of mixed Myc/miRNA FFLs in
which all the regulatory interactions are experimentally validated,
and a set of statistical and functional tests to show the over-
representation of the FFLs in the globally regulatory network.
Then, as an example of use of our database, we shall discuss a few
FFLs which we found of particular biological relevance and in
which the interplay between transcriptional and post-transcrip-
tional regulation seems to play a special role.
Construction of a list of mixed MYC/miRNA Feed-Forward
Loops in which all the regulatory interactions are
experimentally validated
Merging together three datasets of experimentally verified Myc-
driven interactions and miRNA/target relationships (see Figure 1b
and Materials and Methods for details) we were able to identify
110 independent mixed FFL, involving 23 miRNAs regulated by
Myc and a total of 71 Joint Target genes (the number of FFLs
being larger because a few genes are targeted by more than one
miRNA) and among them there were 31 Joint Target genes
validated by low throughput experiments.
In addition to that, a manual survey of the published literature
allowed us to recognize 33 additional FFLs summing up to a total
of 143 FFLs involving 29 Myc regulated miRNAs and 87 Joint
Target genes. Out of these 143 FFLs, 26 could be classified as
incoherent (type_I), 46 as coherent (type_II) and the remaining 71
could not be associated to any of the two types.
Our results are collected in Supplementary Table S1, where we
listed all the FFLs and reported for each of them the
corresponding characterization and the PUBMED link for each
regulatory interaction. In addition to that, in Supplementary
Table S2 we listed the complete dataset of open and closed circuits
obtained with our analysis. For completeness, we also included in
Supplementary File S1 the list of miRNA/target gene interactions
Figure 1. Construction of a catalogue of mixed Feed-Forward regulatory Loops having MYC as master regulator, in which all the
regulatory interactions are experimentally validated. a) Representation of a typical mixed single miRNA/Transcription Factor FFL having MYC
as master regulator: MYC regulates a miRNA and together with it, a Joint Target protein-coding gene. According to the arrows direction, the mixed
FFLs can be classified as incoherent (type I) or coherent (type II) circuits. b) Dataset used for the construction of the mixed FFLs catalogue.
doi:10.1371/journal.pone.0014742.g001
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targeted by Myc.
In Figure 2a we reported a graphical representation of the
resulting network of Myc-centred mixed FFLs database. In addition,
we have recently released an user friendly web server, CircuitsDB -
as interface to the catalogues of computational predicted mixed
FFLs, in human and mouse that we previously developed [12,24].
We added a new section to CircuitsDB devoted to the MYC FFL,
thus allowing an user to browse on-line our data and to follow the
miRNAs and Target gene annotations. CircuitsDB isfreely available
at http://biocluster.di.unito.it/circuits.
Statistical and Functional analysis of the MYC/miRNAs
Regulatory Network
Mixed FFLs over-representation. As discussed in the
introduction, one of the aims of our work was to use our dataset
to test in an unbiased way the over-representation of mixed FFLs
in the Myc/miRNA regulatory network. This is the reason for
which in the previous section we separated the manually curated
FFLs (the last 33) from those obtained performing an unbiased
intersection of Myc/target and miRNA/target (TarBase and
miRecords) databases. To test if the FFLs are over-represented, we
performed an independent permutation test for each link of the
FFL. In order to eliminate a possible experimental bias in this test,
we filtered the data from TarBase and miRecords keeping only
miRNA/Target gene interactions inferred by low throughput
experiments. In all the three tests we found a significant
enrichment of our FFLs with respect to the random samples.
We report the results of this analysis in Figure 2b. To show the
statistical significance we calculated the Z-score (Z) of the number
of Joint Target genes in the closed circuits for each randomization
(MYC R Target Gene reshuffling: Z=3.5; miRNA R Target
Gene reshuffling: Z=4.5 and MYC R miRNA reshuffling:
Z=7.7). A detailed description of the tests can be found in the
Supplementary Material S1 (section S3). We also performed the
same test considering all the miRNA/target gene interactions from
miRecords and TarBase. Also for these tests, results and details are
reported in Supplementary Material S1 (section S3, Figure S1 and
Figure S2).
Mixed FFLs redundancy. Looking at Table S1 and Figure 2a
it is easy to see that a remarkable feature of the Myc-centred FFL
network is that, at least for a few FFLs, it is strongly redundant on
the miRNA side. Moreover this redundancy seems to be associated
to targets, like PTEN, VEGF, E2F1 or Myc itself, which are all
master regulators playing a major role in several biological
processes. It is important to notice that this redundancy is highly
non trivial since it is not simply due to miRNAs belonging to the
same cluster but instead involves miRNAs belonging to different
Transcriptional Units [25] and characterized by different ‘‘seeds’’.
It is difficult to assign a statistical significance to this redundancy
since it is obviously biased by the relevance of the targets, but we
guess that it is not random and was selected by evolution to
enhance the robustness and flexibility of these circuits.
Functional annotations. The targets of the mixed Myc-
centred FFLs show a remarkable enrichment in functional
categories involved in cell cycle regulation and in various types
of cancer (see Table 1).
It is important to notice that this enrichment is indeed a general
property of the genes targeted by the miRNAs under the control of
Figure 2. Properties of the mixed FFLs. a) Graphical representation of the network obtained combining together all the MYC-centred mixed
FFLs. MYC is depicted in green, nodes in red (diamonds) correspond to miRNAs, whereas the blue ones (ellipses) correspond to Joint Targets.
Biological relationship between two nodes is represented as an edge (edges in green identify targets regulation by Myc, black edges evidence the
miRNAs regulation by Myc and in red the targets regulated by miRNAs). b) Randomization results for the over-representation analysis of Myc induced
mixed FFLs validated with low throughput experiments. We plotted the number of Joint Target genes obtained in the real Myc network, alongside
the distributions (normalized histograms) of the number of Joint Target genes detected in the three randomization strategies adopted c) A few
interesting examples of FFLs, having as Joint Target: (1)PTEN, (2)RB1 and (3)VEGF.
doi:10.1371/journal.pone.0014742.g002
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S4). What is remarkable is the fact that this enrichment is
somehow concentrated in the set of FFLs targets and seems to
disappear if the same analysis is performed on the targets of the
open circuits (see Table S3).
miRNA/Target co-localization and co-regulation. A
mandatory condition for FFLs to play a functional role in the
cell is the simultaneous presence in the same tissue of the genes
and miRNAs involved in the FFL. Even if we concentrated in our
work only on experimentally validated interactions, this does not
automatically guarantee that the FFL is actually realized in a given
tissue. In order to address this issue, we included in our on-line
database a link to a set of tissue specific microarray results which
can be visualized as a heat map. This tool allows a qualitative
inspection of co-regulation and of a possible involvement of the
various players of the FFL in the same biological context.
Discussion of a few interesting circuits
The best known example of mixed FFLis thec-Myc/E2F1/miR-
17,20a circuit which was discussed for the first time in [26] and
since then has been the subject of several works. Looking at our
database we are able to show that this is indeed a redundant FFL
and that E2F1 is also regulated by miR-106b which acts coherently
with miR-17,20a (even if it belongs to another Transcriptional
Unit). This shows that the complex regulatory network joining c-
Myc and E2F1 [27-28] is even more intricate than expected.
As further examples of the use of our database and of the type of
biological insight that one can reach combining transcriptional
and post-transcriptional regulation, we shall discuss in this section
three other FFLs in which the single regulatory interactions where
all known in the literature but their common involvement in a
closed FFL was not realized before.
1) The MYC/PTEN/miR-106b, miR-93, miR-25, miR-19a,
miR-22, miR-26a, miR-193b, miR-23b circuit
Pten (Platelet-derived endothelial cell growth factor) is a tumour
suppressor gene which plays an important role in various cancer
related pathways. PTEN is known to be the target of several
miRNAs [29-31] and, remarkably enough, most of these miRNAs
are under the control of Myc thus closing a set of parallel FFLs
(Figure 2c (1)).
Of particular interest is the incoherent branch of the circuit,
which is mediated by miR-19a, and by the miR-106b-25 cluster
(via the activation of the hosting gene MCM7).
Following our recent analysis [17], we suggest that this
particular type of FFL should act as a noise buffering circuit and
should guarantee a steady level of the PTEN protein. Indeed it was
recently shown [32] that even subtle variations in the expression of
PTEN are sufficient to promote cancer susceptibility. This
supports the idea that this circuit could have been selected by
evolution to ensure stability of PTEN levels against fluctuations of
upstream regulators.
2) The MYC/RB1/miR-106a, miR-106b and miR-17 circuit
The circuit in Figure 2c (2) plays a key role in cancer
pathogenesis of solid cancer, by controlling the expression of the
retinoblastoma protein (RB1) which is a tumour suppressor and
was shown to be dysfunctional in many types of cancer.
It is a coherent FFL since Myc represses the transcription of
RB1 and at the same activates a set of miRNAs which in turn
inhibit the translation of RB1 [31]. As mentioned in the
introduction it is likely that coherent FFLs like this one should
play the role of post-transcriptional failsafe controls on their
targets. This prediction seems to be in good agreement with the
results of [33] where a detailed study of the miR-106a/RB1
regulatory interaction in colon cancer cells is reported and a
failsafe control role of this miRNA on the level of RB1 is
suggested.
3) The MYC/VEGF/miR-106b, miR-106a, miR-93, miR-34a,
miR-20a, miR-17, miR-16, miR-15a circuit
The Vascular endothelial growth factor (VEGF), is one of the
most important angiogenic growth factors, and is involved in a
host of biological processes ranging from cell migration to
apoptosis. VEGF translation is strictly controlled by at least eight
miRNAs and, as for PTEN, all of these miRNAs are under the
Table 1. Functional Annotation Chart, performed using DAVID Bioinformatics tool.
KEGG pathways Genes p-Value
Benjamini
(corrected p-value)
Pathways in cancer BCL2, E2F1, E2F3, CASP3, EGFR, VEGF, COL4A1, COL4A2, CD1, CDK6, p21,
p27, CDKI2A, JUN, MET, MSH2, RAS, PTEN, RB1, TGFb2, MYC
3.8E-11 1.8E-9
Bladder cancer E2F1, E2F3, EGFR, CD1, CDKI2A, CDKI1A, RAS, RB1, VEGF, MYC, THBS1 8.7E-12 8.4E-10
Chronic myeloid leukemia E2F1, E2F3, CD1, CDK6, CDKI1A, CDKI1B, CDKI2A, RAS, RB1, TGFb2, MYC 3.7E-9 9.1E-8
Small cell lung cancer BCL2, E2F1, E2F3, COL4A1, COL4A2, CD1, CDKI1B, CDK6, PTEN, RB1, MYC 1.2E-8 2.3E-7
Melanoma E2F1, E2F3, CD1, CDKI2A, CDKI1A, CDK6, EGFR, RAS, RB1, PTEN, MET 2.2E-9 7.0E-8
Glioma E2F1, E2F3, CD1,CDKI2A, CDKI1A, CDK6, EGFR, RAS, RB1, PTEN 1.3E-8 2.1E-7
GO Terms Genes p-Value
Benjamini
(corrected p-value)
Response to abiotic stimulus BCL2, CASP3, CD1, CDKI1A, COL1A1, COL3A1, DNMT3B, EGFR, MAT2A, JUN,
MSH2, SLC12A2, RAS, SMC1L1, THBS1, TGFb2, MYC
5.3E-10 8.6E-7
Regulation of cell cycle BCL2, E2F1, EGFR, CASP3, CD1, CDK6, CDKI1A, CDKI1B, CDKI2A, CDC25A, JUN,
MSH2, PTEN, SMC1L1, RB1, MYC
1.1E-9 4.5E-7
We report the Gene Ontology (GO) Terms and KEGG pathways Over-represented among Joint Target Genes, performed using DAVID Bioinformatics tool. For each row
the corresponding Benjamini (corrected for multiple testing) as well as the raw hypergeometric p-values are indicated.
doi:10.1371/journal.pone.0014742.t001
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in Figure 2c (3) can be classified as coherent or incoherent loop,
depending on the action of Myc on its targets.
It would be very interesting to understand if the different
topologies which this FFL may assume, depending on the type of
regulation exerted by Myc, may be associated to the different
functional roles of VEGF.
Conclusion
It has become by now clear that the interplay between
transcriptional and post-transcriptional (miRNA mediated) regu-
lation plays a crucial role in the modulation of gene expression. Up
to a few years ago this issue could be addressed only with
bioinformatic tools. Remarkable results were obtained in this way
but they were unavoidably affected by large numbers of false
positives thus making impossible to assess their validity with
reliable statistical tests and yielding at the same time very
challenging the experimental validation of the predicted interac-
tions. In these last few years thanks to the impressive improvement
of high-throughput technologies, larger and larger databases of
validated interactions appeared, thus making it possible to
construct networks of validated interactions of increasing com-
plexity. In this paper we in particular concentrated on the mixed
network centred on the Myc Transcription Factor.
While it is likely that in the near future further links will be
added to this network due to new experiments, those which are
already known in the literature allowed us to draw a rich and
intricate picture of the Myc-centred mixed regulatory network,
which turns out to be strongly enriched in mixed FFLs.
As mentioned above, in several cases we could also fix the
relative sign of the various regulatory interactions in the FFLs so
that we could distinguish between coherent and incoherent FFLs.
It is important to stress that these two classes of FFLs may lead
to very different behaviours [10,15]. The coherent circuits lead to
a reinforcement of the transcriptional regulation at the post-
transcriptional level and might be important to eliminate the
already transcribed mRNAs when the transcription of a Target
gene is switched off. The incoherent circuits can be used to
stabilize the steady state production of a protein by dumping
transcriptional fluctuations. In a simple TF/Target interaction,
any fluctuation of a master TF could induce a non-linear increase
in the amount of its target products. The presence, among the
targets, of a miRNA that down-regulates the other targets might
represent a simple and effective way to control these fluctuations.
It is interesting to notice that from our data these two classes of
FFLs seem to be enriched in a substantially equivalent way, thus
suggesting that both functions, post-transcriptional failsafe control
and noise reduction are of crucial importance for higher
eukaryotes and are effectively implemented by miRNA mediated
regulation.
At the same time these results allowed us to improve our
understanding of a few non-trivial issues like the remarkable
stability of PTEN levels in normal cells, which could be a
consequence of the incoherent FFL targeting this gene or the high
levels of redundancy of FFLs targeting master regulators, which
could be a way to ensure tight but at the same time flexible
regulation of these master genes.
A future challenge will be to identify systematically new mixed
FFL involving others important Transcription Factors and to
understand their biological function, integrating together the
wealth of experimental data that will be available in the next years.
Under the hypothesis that FFLs are over-represented in the global
Myc/miRNAs network, they could have an important role in
stabilizing gene expression levels against external noise sources
[10,15,17]. It could be of interest to study the noise properties of
the different FFLs and their functional importance.
Materials and Methods
The construction of the curated database of mixed FFLs, having
Myc as master regulator was mainly based on the following
independent resources (Figure 1b):
(Details on all these steps of the analysis can be found in sections
S1-S4 of Supplementary Material S1)
1. MYC R miRNA link: 26 interactions taken from the TransmiR
database [19] plus 20 additional miRNA induced by Myc from
manual literature search.
2. miRNA R Target Gene link: data taken from the TarBase
database, v. 5.0 [20] and from the miRecords database, v. 1.0
[21] for a total of 1276 non redundant interactions.
3. MYC R Target Gene link: data taken from the Myc Target Gene
database [22] comprising a total of 1733 interactions.
The list of Myc-centered mixed FFLs, was then obtained by
merging together the above databases. Random reshufflings of
miRNAs and gene names in the original transcriptional (MYC R
Target Gene and MYC R miRNA) and post-transcriptional
(miRNA R Target Gene) regulatory networks were performed to
assess the statistical significance of the over-representation of the
mixed Myc/miRNA FFLs in the global Myc/miRNA regulatory
network.
To investigate whether the Joint Target genes belonging to our
catalogue of mixed FFLs could be associated to specific biological
function, we looked for GO terms and KEGG pathways
enrichment analysis among them, using the DAVID Bioinfor-
matics tools [23].
Supporting Information
Supplementary Material S1 Supplementary Material Sections
and References: S1) Description of the databases used for the
construction of the mixed FFLs; S2) Identification of additional
mixed FFLs; S3) Additional information on the over-representa-
tion test; S4) Additional information on the functional enrichment
test; References.
Found at: doi:10.1371/journal.pone.0014742.s001 (0.05 MB
DOC)
Table S1 List of the MYC centred mixed FFLs having the single
links experimentally validated with their corresponding PMID
references. The table lists the 143 mixed FFLs, having Myc as
master regulator and characterized only by experimentally verified
interactions. Each line corresponds to a single closed FFL. For the
Joint Target genes, we used the standard HGNC identifiers and
the Ensembl gene id. For the miRNA, stable ids from the miRBase
database. The type of regulation exerted by Myc on miRNA and
Joint Target is indicated, respectively, with Myc_Action 1 and
Myc_Action 2. There are PMID references for each link:
Reference 1: refers to Myc/miRNA interaction, Reference 2:
refers to miRNA/Joint Target interaction and Reference 3: refers
to Myc/Joint Target interaction. We highlighted with (1) symbol
additional FFLs from manual literature search and with (*) symbol
low throughput validation of miRNA/target genes interactions
reported in TarBase or miRecords databases.
Found at: doi:10.1371/journal.pone.0014742.s002 (0.04 MB
XLS)
Table S2 List of all open and closed circuits. The table lists the
565 open and closed circuits having Myc as master regulator and
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PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e14742characterized only by experimentally verified interactions. Each
line corresponds to a single circuit. For the Joint Target genes, we
used the standard HGNC identifiers and the Ensembl gene id. For
the miRNA, stable ids from the miRBase database. The following
symbols indicate: (*) low throughput validation of miRNA/target
genes interactions reported in TarBase and miRecords databases;
if miRNA/target genes interactions were reported in Tarbase or
miRecords (+) and if these interactions were found in literature
(2).
Found at: doi:10.1371/journal.pone.0014742.s003 (0.07 MB
XLS)
Table S3 Functional Annotation Chart, performed using
DAVID Bioinformatics tool. We report only the KEGG pathways
discussed in the main text (see Table 1). We compare the
enrichment levels of the FFL targets, the 316 genes targeted by the
miRNAs which are under the control of Myc and the 662 genes
targeted by miRNAs which are not under the control of Myc.
Found at: doi:10.1371/journal.pone.0014742.s004 (0.01 MB
XLS)
File S1 The list of 662 targets associated to the miRNAs not
targeted by Myc. For the target genes, we used the standard
HGNC identifiers and we highlighted with (*) the miRNA/target
genes interactions experimentally directly validated. For the
miRNA, stable ids from the miRBase database.
Found at: doi:10.1371/journal.pone.0014742.s005 (0.01 MB
TXT)
Figure S1 Distribution of miRNA target genes. We organized
miRNAs in four classes, based on the number of miRNA target
experimentally validated genes interactions.
Found at: doi:10.1371/journal.pone.0014742.s006 (0.02 MB
PNG)
Figure S2 Randomization results for the over-representation
analysis of Myc induced mixed FFLs experimentally validated by
low and high throughput experiments. We plotted the number of
Joint Target genes obtained in the real Myc network, alongside the
distributions (normalized histograms) of the number of Joint
Target genes detected in the three randomization strategies
adopted.
Found at: doi:10.1371/journal.pone.0014742.s007 (0.02 MB
PNG)
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